Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma
Sanofi
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences

      This is a phase I study to evaluate the safety of concurrent chemoradiation combining
      radiotherapy (IGRT) with two cytotoxic agents, capecitabine and oxaliplatin in patients with
      advanced or inoperable hepatocellular carcinoma.
    
Drug